Key Market Indicators
Sales of digestive system disorder medicine in Japan are set to reach $4.4 billion by 2026. In 2021, the market was valued at $4.5 billion, a decrease of 0.4% year-on-year. Since 1985, the average annual growth rate of the Japanese market has been 4.3%. In 2021, Germany held the top spot, valued at $4.5 billion, followed by Japan, South Korea and Canada.
